Cardlytics (CDLX) Tops Q3 EPS by 26c, Misses on Revenue
Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.07), $0.26 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $52 million versus the consensus estimate of $67.33 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
